Mayo Clinic Talks21 Dec 2020

COVID-19 Miniseries Episode 57: Transcending the Valley of Death - COVID-19 mRNA Vaccine Update

This episode was recorded on December 18, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

It is projected that by March of 2021 1:700 Americans will have died of COVID-19. The historic pace of COVID-19 vaccine development was made possible by the countless sacrifices of many individuals across healthcare, research, health and human services, the Department of Defense, and other key sectors. This interprofessional collaboration required many to set life aside and work tirelessly to bring an effective vaccine to market, quickly. While mRNA vaccines have been in development since the 1990s, the COVID-19 vaccine efficacy rate of 95-100% across studied ages, race and ethnicities, and comorbidities is unprecedented. The questions left to answer are, how long will the efficacy last? In larger population studies, what is the safety/allergy/hypersensitivity profile? What impact does the vaccine have on asymptomatic carrier spread? Who shouldn’t get the vaccine? Dr. Greg Poland breaks down everything you need to know about the mRNA COVID-19 vaccines.

Additional Resources:

Mayo Clinic Vaccine Research Page https://www.mayo.edu/research/labs/vaccine-research-group/overview
Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education
https://www.sciencedirect.com/science/article/pii/S0264410X11011881
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(500)

Pulmonary Embolism

Host: Darryl S. Chukta, M.D. Guest: Robert D. McBane, M.D. At times, pulmonary embolism can be very challenging to diagnose. While some patients have a very dramatic presentation, others may have ve...

25 Aug 29min

Innovations and New Options for Cataract Surgery

Host: Darryl S. Chutka, M.D. Guest: Ruti Sella Svetlit, M.D. Cataracts are one of the leading causes of vision impairment, especially among older adults. While cataract surgery has been available for...

18 Aug 21min

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Host: Darryl S. Chutka, M.D. Guest: Stephanie L. Grach, M.D., M.S. Chronic fatigue syndrome is now known as myalgic encephalomyelitis. Despite this change in terminology, there’s still a great deal ...

11 Aug 27min

Pediatric Neck Masses

Host: Darryl S. Chutka, M.D. Guest: Josh P. Wiedermann, M.D. Neck masses in children are commonly seen in a primary care practice. Fortunately, most are benign, although serious causes, including mal...

4 Aug 23min

Eosinophilic Esophagitis

Host: Darryl S. Chutka, M.D. Guest: Karthik Ravi, M.D. Eosinophilic Esophagitis is often misdiagnosed or undiagnosed in primary care settings, yet it’s a common cause of esophageal symptoms. It’s co...

28 Juli 29min

Psoriasis

Host: Darryl S. Chutka, M.D. Guest: Dawn Davis, M.D. Psoriasis is a health condition commonly seen in primary care but one which has evolved significantly in both how we understand the disease as we...

21 Juli 29min

Acne and Rosacea

Host: Darryl S. Chutka, M.D. Guest: Dawn Davis, M.D. Acne and rosacea are two very common skin conditions seen in primary care, yet at times both the diagnosis and management can be challenging. Whi...

14 Juli 30min

Skull Base Tumors

Host: Darryl S. Chutka, M.D. Guests: Jake Eide, M.D. & Rijul Kshirsagar, M.D. Skull base tumors are not commonly seen in a primary care practice, yet it’s important for us to recognize them when the...

7 Juli 25min